Central European Journal of Medicine

, Volume 9, Issue 3, pp 394–399 | Cite as

Orbital Rhabdomyosarcoma with a good life prognosis after surgical treatment in a 14-year-old patient

  • Cristina Nicula
  • Dorin Nicula
  • Mihai Blidaru
  • Adrian Ghiţuică
  • Stefania Neamtu
  • Aniela Saplonţai-Pop
Case Report


The orbital rhabdomyosarcoma is one of the most frequent malignant orbital tumours in children. At this age, the common histological types are the embryonal and alveolar type. The onset is mainly under the age of 16. Without a recent and correct treatment it can give metastasis in lung and bone. The hereby paper presents one clinical case of a teenager presented at the ophthalmological consultation for a small tumor located in the superomedial part of the orbit. Computed tomography (CT) and magnetic resonance imaging (MRI) supported the diagnosis revealing the location and extension of the tumor. During the surgery, we discovered two small tumors and the histological examination revealed an embryonal type of orbital rhabdomyosarcoma. After the surgery, the patient followed an oncological treatment consisting of chemotherapy and local radiotherapy. The prognosis for life was favorable, linked with the recent diagnosis and treatment, the histological type and the good response at the oncological treatment.


Orbital rhabdomyosarcoma Local radiotherapy Chemotherapy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Rootman J, Neoplasia, Diseases of the orbit: a multidisciplinary approach, Lippincott Williams and Wilkins, Philadelphia, 2003, 54, 262–268Google Scholar
  2. [2]
    Jurdy L, Johanus HM, Pieters B, Mourits M, Kloos R, Strackee S, Saeed P. Orbital rhabdomyosarcomas: A review, Saudi J Ophthalmol. 2013, 27(3), 167–175. doi: 10.1016/j.sjopt.2013.06.004PubMedCentralPubMedCrossRefGoogle Scholar
  3. [3]
    Shields JA, Shields CL, Rhabdomyosarcoma: review for the ophthalmologist, Surv Ophthalmol, 2003, 48, 39–57PubMedCrossRefGoogle Scholar
  4. [4]
    Turner JH, Richmon JD, Head and neck rhabdomyosarcoma: a critical analysis of populationbased incidence and survival data, Otolaryngol Head Neck Surg, 2011, 145, 967–973PubMedCrossRefGoogle Scholar
  5. [5]
    Conneely MF, Mafee MF, Orbital rhabdomyosarcoma and simulating lesions, Neuroimaging Clin N Am, 2005, 15, 121–136PubMedCrossRefGoogle Scholar
  6. [6]
    Koopman JH, van der Heiden-van der Loo M, van Dijk MR, Bijlsma WR, Incidence of primary malignant orbital tumours in The Netherlands Eye (Lond), 2011, 25, 461–465Google Scholar
  7. [7]
    Terezakis SA, Wharam MD, Radiotherapy for rhabdomyosarcoma: indications and outcome, Clin Oncol (R Coll Radiol), 2013, 25, 27–35CrossRefGoogle Scholar
  8. [8]
    Sohaib SA, Moseley I, Wright JE, Orbital rhabdomyosarcoma-the radiological characteristics, Clin Radiol, 1998, 53, 357–362PubMedCrossRefGoogle Scholar
  9. [9]
    Neudorfer M, Leibovitch I, Stolovitch C, Dray JP, Hermush V, Nagar H et al. Intraorbital and periorbital tumors in children-value of ultrasound and color Doppler imaging in the differential diagnosis, Am J Ophthalmol, 2004, 137, 1065–1072PubMedCrossRefGoogle Scholar
  10. [10]
    Boparai MS, Dash RG, Clinical, ultrasonographic and CT evaluation of orbital rhabdomyosarcomas with management, Indian J Ophthalmol, 1991, 39, 129–131PubMedGoogle Scholar
  11. [11]
    Staibano S, Franco R, Tranfa F, Mezza E, Lo Muzio L, Strianese D et al. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior, Anticancer Res, 2004, 24, 249–257PubMedGoogle Scholar
  12. [12]
    Viswanathan S, George S, Ramadwar M, Shet T, Arora B, Laskar S et al. Extraconal orbital tumors in children — a spectrum, Virchows Arch, 2009, 454, 703–713PubMedCrossRefGoogle Scholar
  13. [13]
    Kelleher FC, Viterbo A. Histologic and genetic advances in refining the diagnosis of “undifferentiated pleomorphic sarcoma, Cancers (Basel). 2013, 22,5(1):218–233. doi: 10.3390/cancers5010218CrossRefGoogle Scholar
  14. [14]
    Goldblum JR. An approach to pleomorphic sarcomas: can we subclassify, and does it matter?, Mod Pathol., 2014, 27,suppl 1:S39–S46. doi: 10.1038/ modpathol.2013.174PubMedCrossRefGoogle Scholar
  15. [15]
    Kanski JJ, Clinical Ophtalmology, 4th ed., Butterworth Heinemann, Oxford, 1999, 581–582.Google Scholar
  16. [16]
    Kaliaperumal S, Tiroumal S, Rao V, Orbital rhabdomyosarcoma: a case series, Indian J Cancer., 2007, 44(3), 104–107PubMedCrossRefGoogle Scholar
  17. [17]
    George JL, Marchal JC, Orbital tumors in children: clinical examination, imaging, specific progression, Neurochirurgie, 2010, 56(2–3), 244–248PubMedCrossRefGoogle Scholar
  18. [18]
    Forstner D, Borg M, Saxon B, Orbital rhabdomyosarcoma: multidisciplinary treatment experience, Australas Radiol., 2006, 50(1), 41–45PubMedCrossRefGoogle Scholar
  19. [19]
    Silvana G, Roberto De B, Domenico P, Giuseppina S, Ciracì L, Antonio C, Orbital cavitary rhabdomyosarcoma: a diagnostic dilemma, Orbit., 2010, 29(1), 45–47PubMedCrossRefGoogle Scholar
  20. [20]
    Hosoi H, Et Al, A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan, Int J Clin Oncol., 2007, 12(2), 137–145PubMedCrossRefGoogle Scholar
  21. [21]
    Hayes-Jordan A, Andrassy R, Rhabdomyosarcoma in children, Curr Opin Pediatr., 2009, 21(3), 373–378PubMedCrossRefGoogle Scholar
  22. [22]
    Shome D, Honavar SG, Reddy VA, Vemuganti GK, Orbital embryonal rhabdomyosarcoma in association with neurofibromatosis type 1, Ophthal Plast Reconstr Surg., 2007, 23(2), 147–148PubMedCrossRefGoogle Scholar
  23. [23]
    Sanz-Marco E, España E, Alamar A, Pérez-Rojas J, López-Prats MJ, Díaz-Llopis M. Orbital alveolar rhabdomyosarcoma masked by ethmoid sinusitis in a 25-year-old, Arch Soc Esp Oftalmol., 2012, S0365-6691(12)00538-2. doi: 10.1016/j. oftal.2012.10.012Google Scholar
  24. [24]
    Colović N, Jurišić V, Terzić T, Jevtovic D, Colović M. Alveolar granulocytic sarcoma of the mandible in a patient with HIV, M. Onkologie, 2011, 34, 55–58. doi:10.1159/000317351CrossRefGoogle Scholar
  25. [25]
    Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma — a report from the intergroup rhabdomyosarcoma study IV, J Clin. Oncol., 2003, 21, 78–84PubMedCrossRefGoogle Scholar
  26. [26]
    Olivier Pascual N, Calvo JM, Abelairas Gómez JM, Orbital rhabdomyosarcoma: difficulties with European treatment protocol, Arch Soc Esp Oftalmol, 2005, 80, 331–338PubMedCrossRefGoogle Scholar
  27. [27]
    Raney RB, Maurer HM, Anderson JR, Andrassy RJ, Donaldson SS, Qualman SJ et al., The Intergroup Rhabdomyosarcoma Study Group (IRSG): major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols, Sarcoma, 2001, 5, 9–15PubMedCentralPubMedCrossRefGoogle Scholar
  28. [28]
    Wharam MD, Hanfelt JJ, Tefft MC, Johnston J, Ensign LG, Breneman J et al., Radiation therapy for rhabdomyosarcoma: local failure risk for clinical group III patients on intergroup rhabdomyosarcoma study II, Int J Radiat Oncol Biol Phys, 1997, 38, 797–804PubMedCrossRefGoogle Scholar
  29. [29]
    Shields CL, Shields JA, Honavar SG, Demirci H, Primary ophthalmic rhabdomyosarcoma in 33 patients, Trans Am Ophthalmol Soc, 2001, 99, 133–143PubMedCentralPubMedGoogle Scholar
  30. [30]
    Rosenberg AR, Anderson JR, Lyden E, Rodeberg DA, Wolden SL, Kao SC, Parham DM, Arndt C, Hawkins DS. Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: A report from the Children’s Oncology Group, Eur J Cancer, 2013, S0959-8049(13)01027-7. doi: 10.1016/j.ejca.2013.11.031Google Scholar
  31. [31]
    Breneman J, Meza J, Donaldson SS, Raney RB, Wolden S, Michalski J et al., Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the children’s oncology group D9602 study, Int J Radiat Oncol Biol Phys, 2012, 83, 720–726PubMedCentralPubMedGoogle Scholar
  32. [32]
    Tyl JW, Blank LE, Koornneef L, Brachytherapy in orbital tumors, Ophthalmology, 1997, 104, 1475–1479PubMedCrossRefGoogle Scholar

Copyright information

© Versita Warsaw and Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Cristina Nicula
    • 1
  • Dorin Nicula
    • 2
  • Mihai Blidaru
    • 3
  • Adrian Ghiţuică
    • 4
  • Stefania Neamtu
    • 5
  • Aniela Saplonţai-Pop
    • 6
  1. 1.Department of Ophthalmology“Iuliu Haţieganu” University of Medicine and PharmacyCluj-NapocaRO
  2. 2.Optilens ClinicCluj-NapocaRO
  3. 3.Department of Pathophysiology“Iuliu Haţieganu” University of Medicine and PharmacyCluj-NapocaRO
  4. 4.Department of PathologyMilitary HospitalCluj-NapocaRO
  5. 5.Department of Pediatric Oncology“Ion Chiricută” Oncological InstituteCluj-NapocaRO
  6. 6.Faculty of General Medicine„Iuliu Haţieganu” University of Medicine and PharmacyCluj-NapocaRO

Personalised recommendations